Navigation Links
Effective Screening Required to Rule out Prostate Cancer

Currently, doctors rely on a digital rectal exam and prostate specific antigen (PSA) when a man undergoes a prostate cancer screening.//But doctors say there are other risk factors that could play a role. Researchers from Chicago and The Johns Hopkins Medical Institution investigated how to develop a model to accurately determine the risk of prostate cancer by including seven different risk factors.

A new study finds looking at seven different combined risk factors for prostate cancer is helpful in determining if a patient needs a prostate biopsy. For the study, researchers created a database including 3,268 men recently evaluated for the early detection of prostate cancer. The seven prostate cancer risk factors included age, race, family history, International Prostate Symptom Score, digital rectal exam and two different PSA scores. Researchers say 348 men in the database underwent prostate biopsies. Then researchers created a model that could help determine who is at the greatest risk for prostate cancer when all seven risk factors are considered.

Researchers found the model is helpful at determining who should have a prostate biopsy. They found all seven risk factors played a role in the patient’s outcome. Authors say the new model gives patients a better understanding of their cancer risk and will help them decide to choose to have or not have a biopsy. The authors of the study hope this new model can be used in a clinical setting in the future.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
4. Fluoride Found Effective in Osteoporosis
5. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
6. Implantable Contact Lens Found Safe and Effective
7. Effective And Economical Agent For Anthrax
8. Stem Cell Transplants May Be Effective For MS Patients
9. Effective therapy for Huntingtons disease
10. Chemotherapy Effective for Bladder Cancer
11. Drug Effective for Vascular Dementia

Post Your Comments:
(Date:11/9/2009)...s finds differences in mood despite similar weight...) -- Both a high-fat, low-carbohydrate diet such a...arb diet appear to help people lose pounds over th...e low-fat diets will result in long-term improveme...ue of Archives of Internal Medicine . , People...
(Date:11/9/2009)...ina, Nov. 9 /PRNewswire-FirstCall/ - Hard To Treat...ed today that Novartis, a US$41 billion internatio...in HTDS, H1N1 Vaccine partner, Zhejiang Tianyuan B...ovartis of Switzerland will begin a five-year, $1 ...y will dramatically increase its investment in its...
(Date:11/9/2009)... Course, to be Offered in April 2010, Provi... Cambridge, MA (Vocus) Novemb...r Human Rights (PHR) first inspected a suspected ...alized he would need a team of experts to help int...e properly was a key first step in securing eviden...
(Date:11/9/2009)..., Calif., Nov. 9 Actress Mariska H... philosophy on Saturday to raise awareness abo... throughout California by building healing and wel...its were created to give one to each of the estima... Angeles County,s domestic violence shelters. ,...
(Date:11/9/2009).... 9 Highlighting a commitment to p...vanced entertainment and digital display technolog... Long-Term Care and Hospital Grade LCD HDTVs this ...the Aging 2009 annual meeting and exposition (boot...line of "HealthView(TM)" Long-Term Care LCD HDTVs ...
Breaking Medicine News(10 mins):Health News:To Feel Better, Low-Fat Diet May Be Best 2Health News:To Feel Better, Low-Fat Diet May Be Best 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5
...s,International, Inc. (NYSE: WTW ) will release i...YSE close on Thursday, July 31, 2008., The Compan...t at 5:00,p.m. ET. During the conference call, Dav...s from the investment community., Live audio of t...
...l Combat Veterans, WASHINGTON, July 9 Combat vet...er assistance in 39 additional,communities across ...rs,(VA) will develop Vet Centers by fall 2009., "...terans Affairs. "I,m pleased we can expand access ...
...pitals, WASHINGTON, July 9 CNN reported this mor... System (Corpus Christi TX),received overdoses of ...DT,one of the babies has died; another is in criti...Group,s number one,safety measure that it urges al...
... of new lines may be done without destroying embry...- Scientists say they have finally succeeded in de... development stage of a blastomere, or a 4-cell st...& Embryology annual conference in Barcelona, m...
...tion of 50 years of publishing groundbreaking rese...3 papers that highlight pivotal research and signi...rgonomics (HF/E). The entire online issue is avail...ystems, environments, tools, and products. As note...
...8 Led by Anna Catriona Phillips of the University...to a hepatitis A vaccine in young healthy adults a... vaccination in older community-based adults. , ...ession (10 am to 12 pm) or early evening session (...
Other Medicine News:Health News:Weight Watchers Announces Second Quarter 2008 Earnings Conference Call 2Health News:VA Vet Centers Coming to 39 Communities 2Health News:Statement of the Leapfrog Group on Hospital Overdose of Up to 17 Babies at CHRISTUS Spohn 2Health News:New Technique Harvests Stem Cells at Earlier Stage 2Health News:New Technique Harvests Stem Cells at Earlier Stage 3Health News:Human Factors Journal celebrates 50 years 2
(Date:11/9/2009)...tCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: AR...d quarter ended September 30, 2009. ,, Arena re...olders in the third quarter of 2009 of $34.8 milli...ocable to common stockholders in the third quarter... a net loss allocable to common stockholders in th...
(Date:11/9/2009)...riGene Technologies, Inc. today announced Royal In...RIFY Tagged Antigen(TM) (Over-expression Lysates) ...s funded by the Knut and Alice Wallenberg Foundati...tematically using Antibody-Based Proteomics. "Gene...high throughput manner is critical for the success...
(Date:11/9/2009)...- Asthmatx, Inc. presented the results of a series...fety of bronchial thermoplasty delivered by the Al...impact allergy practices, this past weekend in a p...ollege of Allergy, Asthma and Immunology (ACAAI), ...re Could Bronchial Thermoplasty (BT) Fit Into Your...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 1ECRI Institute Sees Upward Trend in Hospital Medical Technology Evaluation Activity 5559 2AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 1AccuVein Signs Multiple Country Distribution Agreement in Europe for Vein Illumination Device 5555 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 1Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 2Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 3Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr Robert Garnick as Head of Regulatory Affairs 5551 4
... Lixte,Biotechnology Holdings, Inc. (OTC Bulletin ...rom each of two different types of drugs being,dev...f brain cancers have,activity against human pancre...h, President and CEO of Lixte, said, "Lixte previo... different classes of,pharmacologic agents have si...
...eting with the FDA for the Fabry Program and Init...lights for the Quar...(Nasdaq: FOLD ), a biopharmaceutical company deve...logical chaperones for the treatment of human,gene...r the second quarter,of 2008. On a reported basis ...
Other Medicine Technology:Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 2Amicus Therapeutics Announces Second Quarter 2008 Financial Results 3Amicus Therapeutics Announces Second Quarter 2008 Financial Results 4Amicus Therapeutics Announces Second Quarter 2008 Financial Results 5Amicus Therapeutics Announces Second Quarter 2008 Financial Results 6Amicus Therapeutics Announces Second Quarter 2008 Financial Results 7Amicus Therapeutics Announces Second Quarter 2008 Financial Results 8Amicus Therapeutics Announces Second Quarter 2008 Financial Results 9Amicus Therapeutics Announces Second Quarter 2008 Financial Results 10Amicus Therapeutics Announces Second Quarter 2008 Financial Results 11Amicus Therapeutics Announces Second Quarter 2008 Financial Results 12
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: